Connect with us

Hi, what are you looking for?

Latest News

Florida court grants DeSantis’ petition to investigate pharmaceutical companies

The Florida Supreme Court, on Thursday, granted a petition from Gov. Ron DeSantis to have a grand jury investigate any wrongdoing by COVID-19 vaccine manufacturers.

DeSantis has claimed that ‘authoritarians’ wanted to mandate the vaccination of people, and he did what he could to protect Floridians from having that happen and instead leave the choice up to individuals whether to get vaccinated or not.

‘The authoritarians wanted to institute a vaccine passport system almost like a social credit system, so that people who dissented from this would be marginalized from society entirely. We rejected that, and we banned it,’ the Florida governor told Laura Ingraham on ‘The Ingraham Angle’ last week. ‘At the end of the day, what we’re looking for is to provide truth, to provide accurate data, and provide accurate analysis.’

In his request to the Florida Supreme Court, DeSantis suggested a grand jury could seek out additional information from pharmaceutical companies about the vaccines and their potential side effects.

DeSantis argued in his request that the vaccine developers incited an environment that led people to think getting a coronavirus vaccine meant they could not spread the virus to others.

The governor announced his petition for a grand jury on Dec. 13.

‘In Florida, it is against the law to mislead and to misrepresent, particularly when you’re talking about the efficacy of a drug,’ he said.

The grand jury, oftentimes made up of 18 members, will convene for 1 year.

This post appeared first on FOX NEWS
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Economy

    Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...

    Investing

    Bayerische Motoren Werke AG (ETR: BMW) shares have advanced more than 15% since the beginning of October 2022, and the current share price stands...

    Editor's Pick

    In Risky Business: Why Insurance Markets Fail and What to Do About It (Yale University Press, 2023), economists Liran Einav (Stanford), Amy Finkelstein (MIT),...

    Editor's Pick

    Real gross domestic product rose at a revised 3.2 percent annualized rate in the third quarter versus a 0.6 percent rate of decline in...



    Disclaimer: impactofincome.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2023 impactofincome.com